Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene

被引:76
|
作者
Yun, J
Schöneberg, T
Liu, J
Schulz, A
Ecelbarger, CA
Promeneur, D
Nielsen, S
Sheng, H
Grinberg, A
Deng, CX
Wess, J
机构
[1] NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA
[2] Free Univ Berlin, Inst Pharmakol, Fachbereich Humanmed, D-1000 Berlin, Germany
[3] Georgetown Univ, Dept Med, Div Endocrinol & Metab, Washington, DC 20057 USA
[4] Aarhus Univ, Inst Anat, Dept Cell Biol, DK-8000 Aarhus, Denmark
[5] NICHHD, Lab Mammalian Genes & Dev, Bethesda, MD 20892 USA
[6] NIDDKD, Biochem & Metab Lab, Bethesda, MD 20892 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2000年 / 106卷 / 11期
关键词
D O I
10.1172/JCI9154
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The V2 vasopressin receptor (V2R) plays a key role in the maintenance of a normal body water balance. To generate an in vivo model that allows the physiological and molecular analysis of the role of V2Rs in kidney function, we have created mouse lines that lack functional V2Rs by using targeted mutagenesis in mouse embryonic stem cells. Specifically, we introduced a nonsense mutation known to cause X-linked nephrogenic diabetes insipidus (XNDI) in humans (Glu242stop) into the mouse genome. V2R-deficient hemizygous male pups showed a decrease in basal urine osmolalities and were unable to concentrate their urine. These pups also exhibited an enlargement of renal pelvic space, failed to thrive, and died within the first week after birth due to hypernatremic dehydration. Interestingly, female mice heterozygous for the V2R mutation showed normal growth but displayed an XNDI-like phenotype, characterized by reduced urine concentrating ability of the kidney, polyuria, and polydipsia. Western blot analysis and immunoelectron microscopic studies showed that the loss of functional V2Rs had no significant effect on the basal expression levels of aquaporin-2 and the bumetanide-sensitive Na-K-2Cl cotransporter (BSC-1). The V2R mutant mice described here should serve as highly useful tools for the development of novel therapeutic strategies for the treatment of XNDI.
引用
收藏
页码:1361 / 1371
页数:11
相关论文
共 50 条
  • [41] RENAL V2 VASOPRESSIN RECEPTOR PROTEINS - IDENTIFICATION AND ENRICHMENT
    FAHRENHOLZ, F
    KOJRO, E
    PLAGE, G
    MULLER, M
    JOURNAL OF RECEPTOR RESEARCH, 1988, 8 (1-4): : 283 - 294
  • [42] Structural basis of tolvaptan binding to the vasopressin V2 receptor
    Liu, Hong-li
    Zhong, Hai-yang
    Zhang, Yi-xiao
    Xue, Hua-rui
    Zhang, Zheng-shuo
    Fu, Ke-quan
    Cao, Xu-dong
    Xiong, Xiao-chun
    Guo, Dong
    ACTA PHARMACOLOGICA SINICA, 2024, : 2441 - 2449
  • [43] Deletion of the V2 vasopressin receptor gene in two Chinese patients with nephrogenic diabetes insipidus
    Yan Dong
    Haihui Sheng
    Xueru Chen
    Jun Yin
    Qing Su
    BMC Genetics, 7
  • [44] Novel Mutations in the Vasopressin V2 Receptor Gene in Hungarian Children With Nephrogenic Diabetes Insipidus
    Csaba Szalai
    Dimitra Triga
    Antal Czinner
    Pediatric Research, 1997, 42 (3) : 408 - 408
  • [45] Administration of oxytocin affects vasopressin V2 receptor and aquaporin-2 gene expression in the rat
    Terashima, Y
    Kondo, K
    Oiso, Y
    LIFE SCIENCES, 1999, 64 (16) : 1447 - 1453
  • [46] MOLECULAR DEFECT IN THE VASOPRESSIN V2 RECEPTOR GENE CAUSING NEPHROGENIC DIABETES-INSIPIDUS
    KOLAKOWSKI, LF
    HOLTZMAN, EJ
    AUSIELLO, DA
    FASEB JOURNAL, 1993, 7 (07): : A1114 - A1114
  • [47] Deletion of the V2 vasopressin receptor gene in two Chinese patients with nephrogenic diabetes insipidus
    Dong, Yan
    Sheng, Haihui
    Chen, Xueru
    Yin, Jun
    Su, Qing
    BMC GENETICS, 2006, 7 (1)
  • [48] Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus
    Cheong, HI
    Park, HW
    Ha, IS
    Moon, HN
    Choi, Y
    Ko, KW
    Jun, JK
    NEPHRON, 1997, 75 (04): : 431 - 437
  • [49] Conivaptan:: A dual receptor vasopressin V1a/V2 antagonist
    Ali, Farhan
    Raufi, M. Adnan
    Washington, Barbara
    Ghali, Jalal K.
    CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (03): : 261 - 279
  • [50] Sex differences in vasopressin V2 receptor expression and vasopressin-induced antidiuresis
    Liu, Jun
    Sharma, Nikhil
    Zheng, Wei
    Ji, Hong
    Tam, Helen
    Wu, Xie
    Manigrasso, Michaele B.
    Sandberg, Kathryn
    Verbalis, Joseph G.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2011, 300 (02) : F433 - F440